MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 4 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $23.67 (126.48% upside)

Analysts' Ratings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016Stifel NicolausReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Maxim GroupUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2015Maxim GroupReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015Maxim GroupReiterated RatingSell$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015BarclaysInitiated CoverageEqual Weight$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015JPMorgan Chase & Co.Initiated CoverageOverweight$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/9/2015Cowen and CompanyReiterated RatingHold$23.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Leerink SwannReiterated RatingBuy$25.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Brean CapitalReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Brean CapitalReiterated RatingBuy$31.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015Leerink SwannReiterated RatingOutperform$26.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Sanford C. BernsteinReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2015Sanford C. BernsteinBoost Price TargetOutperform$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Goldman SachsDowngradeBuy -> Neutral$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Cowen and CompanyReiterated RatingHold$18.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Leerink SwannBoost Price TargetOutperform$25.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Brean CapitalReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Stifel NicolausBoost Price TargetBuy$26.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Brean CapitalBoost Price TargetBuy$25.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015Stifel NicolausInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Brean CapitalReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Leerink SwannBoost Price TargetOutperform$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Leerink SwannBoost Price TargetOutperform$16.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2015Brean CapitalBoost Price TargetBuy$15.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Brean CapitalReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Maxim GroupSet Price TargetSell$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Maxim GroupDowngradeBuy -> Sell$17.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Brean CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2014Maxim GroupInitiated CoverageBuy$24.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Goldman SachsInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Maxim GroupInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaUpgradeUnderperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha